EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Carcinoma of Esophagus

Joseph Sung iD, Dongxin Lin, Rebecca Fitzgerald, Prateek Sharma, Simon Law, David Ilson

Journal of Gastroenterology and Hepatology · 2025-08 · 40 (8) · 1861-1875

DOI: 10.1111/jgh.16990 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 24.06.2025. Verfasst von Joseph Sung und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Adenocarcinoma, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carcinoma of esophagus is one of the most common cancer worldwide, but its epidemiology is changing. Squamous cell carcinoma is declining in the East, but adenocarcinoma is rising in the West, probably related to the pandemic of obesity and changing lifestyle. Screening of esophageal cancer (both endoscopic and nonendoscopic methods) is recommended in patients suffering from long‐term acid reflux symptoms associated with high‐risk factors and surveillance in patients with Barrett's esophagus. Endoscopy with virtual chromoendoscopy, endoscopic ultrasound, and CT scan is essential for diagnosis and staging of the disease. Endoscopic therapy can be used to treat early diseases. Surgery remains a mainstay treatment. Multimodality treatment strategies involving combinations of chemotherapy, radiotherapy, and more recently immunotherapy and target therapies are gaining momentum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsAdenocarcinomaCarcinoma, Squamous CellHumansRisk FactorsEsophagoscopyCombined Modality TherapyBarrett EsophagusGastroesophageal RefluxNeoplasm StagingEarly Detection of Cancer

Autor:innen und Institutionen

  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
  • Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, China.
  • Early Cancer Institute, University of Cambridge, Cambridge, UK.
  • School of Medicine, University of Kansas, Kansas, USA.
  • Department of Surgery, School of Clinical Medicine, University of Hong Kong, Hong Kong.
  • Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.

ORCID-Profile: Joseph Sung

Förderung

  • NCI NIH HHS

Zitieren

APA

Sung, J., Lin, D., Fitzgerald, R., Sharma, P., Law, S., & Ilson, D. (2025). Carcinoma of Esophagus. Journal of Gastroenterology and Hepatology, 40(8), 1861-1875. https://doi.org/10.1111/jgh.16990

Vancouver

Sung J, Lin D, Fitzgerald R, Sharma P, Law S, Ilson D. Carcinoma of Esophagus. Journal of Gastroenterology and Hepatology. 2025;40(8):1861-1875. doi:10.1111/jgh.16990

BibTeX
@article{Sung2025,
  author = {Sung, Joseph and Lin, Dongxin and Fitzgerald, Rebecca and Sharma, Prateek and Law, Simon and Ilson, David},
  title = {Carcinoma of Esophagus},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2025},
  volume = {40},
  number = {8},
  pages = {1861--1875},
  doi = {10.1111/jgh.16990}
}
Kostenlos starten →